PharmaCyte Biotech, Inc.

NASDAQ:PMCB

1.14 (USD) • At close July 2, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Omzet 000000000000.0120.0670.1260.2630.6531.191.170.5370.0860.00200
Kosten van de omzet 000000000000.010.0190.0320.2290.4270.2660.17100.0410.00100
Brutowinst 000000000000.0030.0470.0940.0340.2260.9240.9990.5370.0450.00200
Brutowinstmarge 000000000000.2090.7090.7450.130.3460.7760.85410.5210.67300
Onderzoek- en ontwikkelingskosten 0.4070.4690.6910.9160.3010.461.9981.1821.4073.4770000.0090.4920.4740.4130.1340.1191.1081.40900
Algemene en administratieve kosten 4.795.9873.7012.7073.5253.6414.9843.264.6669.98818.1070.9020.8240.4711.2395.335006.5590000
Verkoop- en marketingkosten 1.3221.2351.54501.5871.5552.2211.9711.8720.2310.8720.1060.0110.0110.4120.594001.1940000
Verkoop-, algemene en administratieve kosten 2.1174.7522.1562.7073.5253.6414.9843.264.6662.82718.9791.0080.7540.4731.6515.7944.264.4727.7531.7220.3140.0320
Overige kosten 00.202-0.004-0.001-00.0330.1532.5150.0113.338-5.8950.6791.1610.1043.50800000000.03
Bedrijfskosten 6.526.4554.3923.6233.8264.1016.9814.4426.07313.69518.9791.6871.9960.4825.6516.2684.6734.6067.8721.7671.7220.0320.03
Bedrijfsresultaat -8.52-6.455-4.392-3.623-3.826-4.101-6.981-4.442-6.073-13.695-18.979-1.684-1.949-0.388-2.109-6.177-3.749-3.607-7.335-1.722-1.732-0.032-0.03
Bedrijfsresultaat ratio 00000000000-138.517-29.285-3.082-8.021-9.457-3.151-3.084-13.658-19.942-726.85400
Totaal overige inkomsten en kosten netto 8.8542.140.1530.072-00.0330.153-0.0020.0092.841-8.2750.0860.05-0.838-3.8830-0.043-0.007-1.761-0.1141.73200
Inkomen voor belasting 0.334-4.316-4.239-3.551-3.827-4.067-6.829-4.444-6.064-9.928-27.254-1.598-1.899-1.226-5.992-6.029-3.815-3.614-9.033-1.837000
Inkomen voor belasting ratio 00000000000-131.423-28.536-9.731-22.789-9.231-3.206-3.09-16.821-21.262000
Belastingkosten 0-1.937-0.1530.0030-0.033-0.153-0.004-0.0050.0050.020.154-0.051.0093.883-00.0430.0072.050.1141.7250.0320.03
Nettowinst 0.334-4.316-4.086-3.554-3.827-4.067-6.829-4.444-6.064-10.855-27.254-1.598-1.899-1.398-5.992-6.042-3.792-3.614-9.385-4.277-1.736-0.032-0.03
Nettowinstmarge 00000000000-131.423-28.536-11.093-22.789-9.25-3.187-3.09-17.476-49.516-728.47900
WPA (Winst Per Aandeel) -1.8-0.22-0.27-2.46-4.23-5.55-10.57-7.89-12.09-23.11-70.06-5.43-7.6-5.98-29.81-44.98-33.86-33.36-102.95-61.74-27.4-0.55-0.51
Verwaterde WPA -1.8-0.22-0.27-2.46-4.23-5.55-10.57-7.88-12.08-23.11-70.06-5.43-7.6-5.98-29.81-44.98-33.86-33.36-102.95-61.74-27.4-0.55-0.51
EBITDA 0-4.316-4.239-3.624-3.82600-4.4420-9.923-27.233-1.684-1.633-0.348-2.109-6.148-3.743-3.606-7.335-1.722-1.732-0.032-0.03
EBITDA ratio 00000000000-138.517-24.541-2.759-8.021-9.413-3.145-3.083-13.658-19.942-726.85400